Stanley Nathan Caroff MD

Professor of Psychiatry at the University of Pennsylvania, and the Department of Veterans Affairs Medical Center in Philadelphia

Join to view full profile

3900 Woodland AvePhiladelphia Va Medical CenterPhiladelphia, PA 19104

Dr. Caroff is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Caroff's full profile Already have an account?

Summary

Dr. Stanley Caroff is a Philadelphia-based psychiatrist and a Professor of Psychiatry at the University of Pennsylvania Perelman School of Medicine, with expertise in psychopharmacology and specific research interests in drug-induced conditions such as tardive dyskinesia, neuroleptic malignant syndrome, and catatonia. He served as Chief of Inpatient Services at the Corporal Michael J. Crescenz VA Medical Center for over three decades and holds the position of Vice-President of the Malignant Hyperthermia Association of the United States. He completed his psychiatry residency at the SUNY at Stony Brook and the Montefiore Medical Center and pursued further fellowship training in psychopharmacology at the University of Pennsylvania Perelman School of Medicine. Dr. Caroff graduated from the Icahn School of Medicine and holds a BA in Anthropology from Columbia University. His work includes numerous publications, books and clinical trials, along with receiving several honors, including the I.S. Ravdin Master Clinician Award, the Earl D. Bond Award, the Mitchell B. Balter Award and being a founding member of the Academy of Master Clinicians at the Perelman School of Medicine.

Home - MHAUS

Home:

Neuroleptic Malignant Syndrome Information Service

NMSIS is a non-profit organization, an affiliate of the Malignant Hyperthermia Association of the US, which serves as an educational and consultative resource.

Education & Training

University of Pennsylvania Health SystemFellowship, Psychopharmacology, 1979 - 1981
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Psychiatry, 1978 - 1979
Stony Brook Medicine/University HospitalResidency, Psychiatry, 1976 - 1978
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1975 - 1976
Icahn School of Medicine at Mount SinaiClass of 1975

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 1976 - Present
NJ State Medical License 2015 - 2027
PA State Medical License 1979 - 2026
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Member The Cochrane Collaboration, 2022
Mitchell B. Balter Award Journal of Clinical Psychopharmacology, 2021
Founding Member, Academy of Master Clinicians Perelman School of Medicine, University of Pennsylvania, 2014

Clinical Trials

Treatment of Tardive Dyskinesia With Galantamine Start of enrollment: 2002 Jan 01
Completed
Phase 4
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates Start of enrollment: 2019 Jan 01
Recruiting
Phase 4

Publications & Presentations

PubMed

White matter microstructural alterations as a biomarker for classifying catatonic signs.
Stanley N Caroff
Molecular Psychiatry. 2026-05-01
Literary case study of psychosis:.
Gabor S Ungvari, Stanley N Caroff, Levente Csihi, Gábor Gazdag
World Journal of Psychiatry. 2025-06-19
2 citations
A validation study of the Clinician's Tardive Inventory (CTI).
Richard M Trosch, Alicia C Shillington, Cynthia L Comella, Stanley N Caroff, William G Ondo
Parkinsonism & Related Disorders. 2025-06-01

Journal Articles

Neurosurgery for mental conditions and pain: An historical perspective on the limits of biological determinism
Coffey RJ, Caroff SN, Surgical Neurology International, 12/28/2024
First 150 years of catatonia: Looking back at its complicated history and forward to the road ahead.
Csihi L, Gazdag G, Caroff SN, Ungvari GS, World J Psychiatry, 5/1/2024
Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders. CNS Drugs
Vanegas-Arroyave N, Caroff SN, Citrome L, et al, CNS Drugs, 4/1/2024

Books/Book Chapters

Clincial Manual of Psychopharmacology in the Medically Ill
Chapter: Severe Drug Reactions
Page 51 - 118E. Cabrina Campbell, Stanley N. Caroff, Stephan C. Mann, Robert M. Weinrieb, Rosalind M. Berkowitz, Kimberly N. OlsonEditors: James L. Levenson, Stephen J. Ferrando.American Psychiatric Association Publishing, Washington, D.C.Edition 3rd,2023
Movement Disorder Emergencies
Chapter: Neuroleptic malignant syndrome
Page 95 - 113Caroff SN, Mann SC, Sullivan KA, Campbell ECEditors: Frucht SJ.Springer Nature Switzerland AGEdition 3rd,2022
Antipsychotic Trials in Schizophrenia: The CATIE Project
Chapter: Extrapyramidal side effects
Page 156 - 172Caroff SN, Miller DD, Rosenheck RAEditors: Stroup TS, Lieberman JA.Cambridge University Press, Cambridge2010

Lectures

Advances in the diagnosis and treatment of tardive dyskinesia
Henry Stewart Talks Ltd., Ruskin House, 40/41 Museum Street, London, WC1A 1LT - 7/16/2024
Identification and Management of Tardive Dyskinesia: Best practices to promote real-world practice change in the long-term-care setting,
clinicaloptions.com/events/td-II-2024/10742 - 6/21/2024
Catatonia: From Psychopathology to Neurobiology
https://clinicaloptions.com/CE-CME/psychiatry/catatonia-2024-psych-summit/19398-33208 - 5/18/2024

Authored Content

The Return of Psychedelics: Still Time to Prevent TragedyMarch 2021

Press Mentions

Psychosurgery Is Back. But These Are Not the Ice-Pick-Through-the-Eye-Socket Lobotomies of the PastJuly 15th, 2025
What Is Tardive Dyskinesia (TD)? Symptoms, Causes And TreatmentsMay 16th, 2023
Tardive Dyskinesia Linked with Medical Comorbidity in VeteransMay 21st, 2019

External Links

NMSIShttp://www.nmsis.org
MHAUShttp://www.mhaus.org
Identifying and Treating Tardive Dyskinesia 2023 https://clinicaloptions.com/CE-CME/psychiatry/tardive-dyskinesia/26323